Key Financial’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.4K Hold
225
– – ﹤0.01% 715
2026
Q2
$21.5K Hold
225
– – ﹤0.01% 716
2026
Q1
$21.7K Hold
225
– – ﹤0.01% 711
2025
Q4
$21.9K Hold
225
– – ﹤0.01% 701
2025
Q3
$15.8K Hold
225
– – ﹤0.01% 765
2025
Q2
$13.5K Hold
225
– – ﹤0.01% 775
2025
Q1
$11.8K Hold
225
– – ﹤0.01% 782
2024
Q4
$12.4K Hold
225
– – ﹤0.01% 774
2024
Q3
$11.3K Hold
225
– – ﹤0.01% 762
2024
Q2
$9.9K Hold
225
– – ﹤0.01% 781
2024
Q1
$9.9K Hold
225
– – ﹤0.01% 763
2023
Q4
$10.7K Hold
225
– – ﹤0.01% 719
2023
Q3
$10K Hold
225
– – ﹤0.01% 711
2023
Q2
$10.7K Buy
+225
New +$10.1K ﹤0.01% 703

Other funds holding IRMD

Key Financial's IRMD Position: Q3 2026 in Review

Key Financial held its iRadimed (IRMD) position steady in Q3 2026 at 225 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #715.

Key Financial first reported a position in IRMD in Q2 2023 and has held it in 14 quarters since. The position peaked at $21.9K in Q4 2025. 160 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • Key Financial held 225 shares of iRadimed worth $19.4K as of Q3 2026.
  • Key Financial left its iRadimed share count unchanged in Q3 2026.
  • iRadimed made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #715 holding.
  • Key Financial first reported a position in iRadimed in Q2 2023 and has held it in 14 quarters since.
  • Key Financial's iRadimed position peaked at $21.9K in Q4 2025.
  • 160 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.